Form Bio

AUSTIN, TX · Founded 2022 · CIK 0001944690 · Biotech · Private

AI platform for optimizing AAV vectors and enhancing CRISPR accuracy in genetic medicine manufacturing

form.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$16M
1 Form D · Sep 2022
48 months since last filing
Contracts
—
No federal contracts on record
Patents
9
6 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$16,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2530IpiNovyx Bio, Inc.—$7.0M
2531Lang Artificial Intelligence, Inc.—$11M
2532STEMLINE THERAPEUTICS INC—$2.6M
2533Form Bio—$16M
2534A2 THERAPEUTICS, INC.——
2535Deverra Therapeutics—$2.5M
2536ELIAS Animal Health, LLC—$2.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Andrew BuseyDirector · Executive Officer · Promoter
  • Benjamin LammDirector · Promoter
  • John SpinaleDirector
  • Kent WakefordDirector · Executive Officer · Promoter

Patents

USPTO · 6 granted of 9

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.